Earnings Feed
Start Free
Home/Filings/4/0001140361-10-050291
4//SEC Filing

Bollon Arthur 4

Accession 0001140361-10-050291

CIK 0001301348other
View on SEC.govCompany Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:25 PM ET

Size

16.6 KB

Accession

0001140361-10-050291

Insider Transaction Report

Form 4
Period: 2010-12-13
HEMOBIOTECH, INC.HMBT.OB
Bollon Arthur
DirectorChief Executive Officer
Transactions
  • Award

    Options to Purchase Common Stock

    2009-10-31+96,000→ 196,000 total
    Exercise: $0.25From: 2009-10-31Exp: 2014-10-31→ Common Stock (96,000 underlying)
  • Award

    Options to Purchase Common Stock

    2009-11-30+26,000→ 222,000 total
    Exercise: $0.40From: 2009-11-30Exp: 2014-11-30→ Common Stock (26,000 underlying)
  • Award

    Options to Purchase Common Stock

    2009-12-31+21,000→ 243,000 total
    Exercise: $0.50From: 2009-12-31Exp: 2014-12-31→ Common Stock (21,000 underlying)
  • Award

    Options to Purchase Common Stock

    2010-09-30+7,000→ 250,000 total
    Exercise: $0.30From: 2010-09-30Exp: 2015-09-30→ Common Stock (7,000 underlying)
  • Award

    Options to Purchase Common Stock

    2010-09-30+19,000→ 269,000 total
    Exercise: $0.30From: 2010-09-30Exp: 2015-09-30→ Common Stock (19,000 underlying)
Footnotes (7)
  • [F1]From October 31, 2009 through December 2009, additional options were granted in lieu of monthly salaries.
  • [F2]On November 18, 2010, the board of directors of HemoBioTech, Inc. agreed to reprice all options to $.25.
  • [F3]The Options to Purchase Common Stock were granted on October 31, 2009. All Options are immediately vested and exercisable upon issuance.
  • [F4]The Options to Purchase Common Stock were granted on November 30, 2009. All Options are immediately vested and exercisable upon issuance.
  • [F5]The Options to Purchase Common Stock were granted on December 31, 2009. All Options are immediately vested and exercisable upon issuance.
  • [F6]The Options to Purchase Common Stock were granted on September 30, 2009. All Options are immediately vested and exercisable upon issuance.
  • [F7]The Options to Purchase Common Stock were granted on September 30, 2009. All Options are immediately vested and exercisable upon issuance.

Documents

1 file

Issuer

HEMOBIOTECH, INC.

CIK 0001301348

→
Entity typeother

Related Parties

1
  • filerCIK 0001329091

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:25 PM ET
Size
16.6 KB
View on SEC.gov